Daiichi Sankyo Submits Benicar/Amlodipine Fixed-Dose Combination To FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Combination of olmesartan and amlodipine can be used alone or in conjunction with other antihypertensives, firm says.
You may also be interested in...
Daiichi Sankyo/Forest’s Hypertension Therapy Azor Gets FDA Nod
Azor will compete against Novartis’ recently approved Exforge.
Daiichi Sankyo/Forest’s Hypertension Therapy Azor Gets FDA Nod
Azor will compete against Novartis’ recently approved Exforge.
Forest, Daiichi Partner To Promote Hypertension Combo Azor Upon Approval
Forest Laboratories and Daiichi Sankyo are building upon an ongoing collaboration for Benicar and Benicar HCT with the signing of a new deal to co-promote the fixed-dose antihypertensive Azor, whose approval is anticipated in September. The companies announced the signing of a letter of intent to enter into a collaboration Aug. 21